[go: up one dir, main page]

WO2002012434A3 - Reseau servant a controler un profil de reponse medicale electronique globale - Google Patents

Reseau servant a controler un profil de reponse medicale electronique globale Download PDF

Info

Publication number
WO2002012434A3
WO2002012434A3 PCT/GB2001/003624 GB0103624W WO0212434A3 WO 2002012434 A3 WO2002012434 A3 WO 2002012434A3 GB 0103624 W GB0103624 W GB 0103624W WO 0212434 A3 WO0212434 A3 WO 0212434A3
Authority
WO
WIPO (PCT)
Prior art keywords
patient
genotype
analysis
given
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2001/003624
Other languages
English (en)
Other versions
WO2002012434A2 (fr
Inventor
Claire Judith Allan
Dirk Erik Pollett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to US10/344,292 priority Critical patent/US20040029138A1/en
Priority to EP01956677A priority patent/EP1356412A2/fr
Priority to AU2001278599A priority patent/AU2001278599A1/en
Publication of WO2002012434A2 publication Critical patent/WO2002012434A2/fr
Anticipated expiration legal-status Critical
Publication of WO2002012434A3 publication Critical patent/WO2002012434A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Analytical Chemistry (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Databases & Information Systems (AREA)
  • Bioethics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

L'invention concerne la gestion de soins médicaux et, plus particulièrement, un procédé basé sur Internet et servant à améliorer et à appliquer la connaissance du rôle joué par la constitution génétique d'un individu dans sa réaction à une thérapie médicamenteuse. Elle concerne, plus particulièrement, un procédé d'utilisation de marqueurs biologiques afin de développer et de prescrire des médicaments, ce qui consiste à prélever un spécimen biologique sur un patient, à transmettre ce spécimen à un système centralisé d'analyse et de stockage, à établir le génotype de ce spécimen au niveau de ce système, à renvoyer au patient par voie électronique l'analyse du génotype à la demande dudit patient ou de son médecin, de manière à permettre à ce dernier d'évaluer le médicament le plus approprié à administrer audit patient à l'examen de son génotype, à transmettre dans les meilleurs délais par voie électronique l'analyse du génotype à un système de révision homologue afin d'en analyser les données, puis à transmettre ces données analysées à une base de données, dans le but de rechercher une ou plusieurs associations entre un génotype donné et une réaction donnée à un médicament donné.
PCT/GB2001/003624 2000-08-10 2001-08-09 Reseau servant a controler un profil de reponse medicale electronique globale Ceased WO2002012434A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/344,292 US20040029138A1 (en) 2000-08-10 2001-08-09 Global electronic medicine response profile testing network
EP01956677A EP1356412A2 (fr) 2000-08-10 2001-08-09 Reseau servant a controler un profil de reponse medicale electronique globale
AU2001278599A AU2001278599A1 (en) 2000-08-10 2001-08-09 A global electronic medicine response profile testing network

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22414600P 2000-08-10 2000-08-10
US60/224,146 2000-08-10

Publications (2)

Publication Number Publication Date
WO2002012434A2 WO2002012434A2 (fr) 2002-02-14
WO2002012434A3 true WO2002012434A3 (fr) 2003-08-14

Family

ID=22839443

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/003624 Ceased WO2002012434A2 (fr) 2000-08-10 2001-08-09 Reseau servant a controler un profil de reponse medicale electronique globale

Country Status (3)

Country Link
EP (1) EP1356412A2 (fr)
AU (1) AU2001278599A1 (fr)
WO (1) WO2002012434A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003237657A1 (en) * 2002-05-24 2003-12-12 Epidauros Biotechnologie Ag Means and methods for improved treatment using "setrones"
JP4090469B2 (ja) 2002-11-18 2008-05-28 株式会社日立製作所 塩基配列関連情報を用いた情報処理システム
WO2004074456A2 (fr) * 2003-02-20 2004-09-02 Mayo Foundation For Medical Education And Research Methodes de selection de medications
US8688385B2 (en) 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
US20060136143A1 (en) * 2004-12-17 2006-06-22 General Electric Company Personalized genetic-based analysis of medical conditions
WO2007064675A2 (fr) 2005-11-29 2007-06-07 Children's Hospital Medical Center Optimisation et personnalisation de selection et de dosage de medicaments
US20100222228A1 (en) * 2006-10-11 2010-09-02 Janssen Pharmaceutica N.V. Compositions and methods for treating and diagnosing irritable bowel syndrome

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996023078A1 (fr) * 1995-01-27 1996-08-01 Incyte Pharmaceuticals, Inc. Memorisation et analyse informatiques de donnees microbiologiques
WO1998013783A1 (fr) * 1996-09-27 1998-04-02 Azron, Incorporated Systeme electronique de fichiers medicaux
WO1998024212A1 (fr) * 1996-11-29 1998-06-04 Micromedical Industries Limited Systeme de telemedecine
US5827180A (en) * 1994-11-07 1998-10-27 Lifemasters Supported Selfcare Method and apparatus for a personal health network
US5935060A (en) * 1996-07-12 1999-08-10 First Opinion Corporation Computerized medical diagnostic and treatment advice system including list based processing
WO2000070556A2 (fr) * 1999-05-19 2000-11-23 Whitehead Institute For Biomedical Research Procede et systeme de gestion de base de donnees relationnelle, permettant de memoriser, comparer et afficher les resultats produits par des analyses de donnees d'ensembles de genes
WO2001016858A2 (fr) * 1999-08-27 2001-03-08 Pluvita Corporation Systeme et procede d'evaluation genomique et proteomique d'une maladie humaine par comparaison de profils d'expression

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827180A (en) * 1994-11-07 1998-10-27 Lifemasters Supported Selfcare Method and apparatus for a personal health network
WO1996023078A1 (fr) * 1995-01-27 1996-08-01 Incyte Pharmaceuticals, Inc. Memorisation et analyse informatiques de donnees microbiologiques
US5935060A (en) * 1996-07-12 1999-08-10 First Opinion Corporation Computerized medical diagnostic and treatment advice system including list based processing
WO1998013783A1 (fr) * 1996-09-27 1998-04-02 Azron, Incorporated Systeme electronique de fichiers medicaux
WO1998024212A1 (fr) * 1996-11-29 1998-06-04 Micromedical Industries Limited Systeme de telemedecine
WO2000070556A2 (fr) * 1999-05-19 2000-11-23 Whitehead Institute For Biomedical Research Procede et systeme de gestion de base de donnees relationnelle, permettant de memoriser, comparer et afficher les resultats produits par des analyses de donnees d'ensembles de genes
WO2001016858A2 (fr) * 1999-08-27 2001-03-08 Pluvita Corporation Systeme et procede d'evaluation genomique et proteomique d'une maladie humaine par comparaison de profils d'expression

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GOULD ROTHBERG B E ET AL: "INTEGRATING EXPRESSION-BASED DRUG RESPONSE AND SNP-BASED PHARMACOGENETIC STRATEGIES INTO A SINGLE COMPREHENSIVE PHARMACOGENOMICS PROGRAM", DRUG DEVELOPMENT RESEARCH, NEW YORK, NY, US, vol. 49, no. 1, January 2000 (2000-01-01), pages 54 - 64, XP000965758, ISSN: 0272-4391 *

Also Published As

Publication number Publication date
WO2002012434A2 (fr) 2002-02-14
AU2001278599A1 (en) 2002-02-18
EP1356412A2 (fr) 2003-10-29

Similar Documents

Publication Publication Date Title
Mash et al. Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures
Ganz Quality of life and the patient with cancer. Individual and policy implications
Basch et al. Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
Center for Substance Abuse Treatment (US) Medication-assisted treatment for opioid addiction in opioid treatment programs
Voineskos et al. Measuring patient-reported outcomes: key metrics in reconstructive surgery
Polcin Issues in the treatment of dual diagnosis clients who have chronic mental illness.
Schlam et al. Can we increase smokers’ adherence to nicotine replacement therapy and does this help them quit?
Potter et al. Substance use histories in patients seeking treatment for controlled-release oxycodone dependence
WO2003019455A3 (fr) Systeme, procede et programme informatique pour surveiller et gerer des medications
TW201640390A (zh) 表型個人化醫療：病患特異性組合治療之適應性最佳化
Berhouma et al. Survey on Tunisian Dentists’ Anti‐Inflammatory Drugs’ Prescription in Dental Practice
Chiò et al. Amyotrophic lateral sclerosis care in Italy: a nationwide study in neurological centers
WO2002012434A3 (fr) Reseau servant a controler un profil de reponse medicale electronique globale
Penna Pharmacy: a profession in transition or a transitory profession?
Alomi et al. Cost analysis of drug information services at the mental hospital in Saudi Arabia
Ganz Quality of life measures in cancer chemotherapy: methodology and implications
CN107194152A (zh) 一种用于评估临床结果的方法
Nyamathi et al. Predictors of hepatitis knowledge improvement among methadone maintained clients enrolled in a hepatitis intervention program
CN114519380A (zh) 一种基于隐私保护及图像识别的给药方法与装置
Winzenborg et al. A Personalized Medicine Approach Using Clinical Utility Index and Exposure‐Response Modeling Informed by Patient Preferences Data
Phillips et al. Moneyball and medicine
Zhao et al. Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective study
Jolly Health workforce: a case for physician assistants?
Maarse et al. The governance of quality management in Dutch health care: new developments and strategic challenges
Tsekouras et al. Re-examining naloxone pharmacokinetics after intranasal and intramuscular administration using the finite absorption time concept

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001956677

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10344292

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001956677

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001956677

Country of ref document: EP